To determine whether ntHIF-1α-TMD shows the therapeutic potential to the animal model with autoimmunity, the mice with EAE, animal model of multiple sclerosis (MS), were treated with ntHIF-1α-TMD as scheduled in Figure 4A. This evidence concerns the gene GDI1 and myeloid sarcoma.